Ibrutinib mediates changes in chromatin structure in chronic lymphocytic leukaemia (CLL): epigenetic studies from the bloodwise TAP IcICLLe trial

Holmes, K, Lefevre, P, Sadreev, I et al. (4 more authors) (2017) Ibrutinib mediates changes in chromatin structure in chronic lymphocytic leukaemia (CLL): epigenetic studies from the bloodwise TAP IcICLLe trial. In: Leukemia and Lymphoma. XVII International Workshop on Chronic Lymphocytic Leukemia, 12-15 May 2017, New York, USA. Taylor and Francis , pp. 19-20.

Metadata

Authors/Creators:
  • Holmes, K
  • Lefevre, P
  • Sadreev, I
  • Munir, T
  • Rawstron, A
  • Westhead, D
  • Hillmen, P
Dates:
  • Published: December 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Funding Information:
FunderGrant number
Bloodwise14016
Depositing User: Symplectic Publications
Date Deposited: 03 Apr 2019 14:05
Last Modified: 03 Apr 2019 14:05
Status: Published
Publisher: Taylor and Francis
Identification Number: https://doi.org/10.1080/10428194.2017.1377942

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics